skip to Main Content

April 20, 2022
Joint Statement from Leading HIV/AIDS and Viral Hepatitis Advocates regarding Manufacturer Action on the 340B Drug Pricing Program
Statement / Press
A group of six leading HIV/AIDS and viral hepatitis advocates today released the following joint statement regarding recent manufacturer action against the 340B Drug Pricing Program:

April 13, 2022
TAG Submission to WHO Public Hearing Regarding a New International Instrument on Pandemic Preparedness and Response
Letter / Comment
At the first of these two public hearings TAG submitted the following statement with six reasons why the new international instrument must explicitly acknowledge the right to science as a central guiding framework.

March 29, 2022
HIV Updates From CROI: The Good, the Bad, and the Long-Acting
Webinar / Presentation
On April 15 TAG presented, “HIV Updates From CROI: The Good, the Bad, and the Long-Acting.” This free webinar unpacked the most significant developments in HIV research presented at the Conference on Retroviruses and Opportunistic Infection (CROI), and what they mean for communities affected by HIV.

March 25, 2022
Viral Hepatitis Diagnostics Working Group Coordinating Consultant
The consultant will support the Viral Hepatitis Diagnostics Working group to engage diagnostics product developers to submit data for FDA approval, engage with US government agencies funding POC research, and build additional technical capacity and regulatory knowledge among WG members.

February 23, 2022
Mourning Paul Farmer, Honoring His Legacy
Statement / Press
TAG’s staff and board of directors are filled with grief at the premature death of Dr. Paul Farmer, who illuminated and changed our world with his combination of passion, intelligence, solidarity with the poor, and determined will for social justice.

February 15, 2022
Submission to the Office of the High Commissioner for Human Rights Input to HRC resolution 47/17
Letter / Comment
On February 9, TAG submitted this testimony to the Office of the High Commission for Human Rights (OHCHR) to inform its upcoming report to the Human Rights Council (HRC) on ‘human rights in the context of HIV/AIDS’ (HRC resolution 47/17).

February 3, 2022
Promoting Interventions for Viral Hepatitis and Harm Reduction in COP 2022
On February 3, 2022, TAG in collaboration with the International Network of People who Use Drugs (INPUD), Harm Reduction International (HRI), and the World Hepatitis Alliance (WHA), hosted this free webinar.

December 16, 2021
2021 TAG Update
As we look forward to an end of an extremely challenging year—and past four years—we reflect on the remarkable resilience and impact of TAG, even and especially in these dark times.

November 4, 2021
Same Meds, New Patents: What Do Activists Need to Know About Long-Acting Technologies
Webinar / Presentation
On November 4, 2021, Treatment Action Group and the International Treatment Preparedness Coalition presented this webinar outlining the main findings of the upcoming report “Hepatitis C and Tuberculosis Long-Acting Medicines: Analysis on Patenting Trends.”

November 4, 2021
Hepatitis C and Tuberculosis Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access
This new report offers recommendations to ensure access to long-acting technologies throughout the research and development process.

October 7, 2021
TAGline October 2021
Delivering on the Promise of Long-Acting Forumulations delves deep into the development of long-acting formulations for the treatment and prevention of infectious diseases like HIV, tuberculosis, hepatitis C, and malaria. Long-acting medications have become common for conditions such as osteoporosis and schizophrenia, and they’re even used for birth control.

September 20, 2021
A Partnership to Expand Access to Lifesaving Testing and Treatment for Hepatitis C
Hepatitis C PACT was launched in 2021 and aims to tackle ongoing disparities in access to diagnostics and treatment for hepatitis C virus (HCV) in low-and middle-income countries (LMICs), home to 75% of people living with the viral illness. This brief explains the group’s goals and  work.

September 11, 2021
Have a Heart, Save My Liver! Who Has Access to the Cure in Africa?
Webinar / Presentation
On September 11 2021, Treatment Action Group’s Joelle Dountio Ofinboudem presented new data on the registration of the hepatitis C cure at the Conference on Liver Disease in Africa (COLDA) 2021. The presentation titled, “Have a Heart, Save My Liver! Who Has Access to the Cure in Africa,” explains that accelerating…

August 27, 2021
Substantial Public Investments in GeneXpert Underscore Need for Affordable Pricing
Statement / Press
TAG’s comprehensive analysis found that the public invested at least $252 million USD in the research and development of GeneXpert diagnostic technology, which stands in stark contrast to the lack of affordable pricing and favorable service and maintenance terms from the diagnostics company Cepheid.

July 28, 2021
Illustrated Glossary for Long-Acting Technologies
The Illustrated Glossary for Long-Acting Technologies compiles frequent terms and concepts used in the research and development of long-acting technologies. The glossary is a non-exhaustive list and the graphics are artistic renderings meant to spur discussion and assist with community treatment literacy. 

Back To Top